脑微出血与抗血栓药物的关系
基于梅奥衰老研究人群的横断面分析纳入1253例接受磁敏感MRI的受试者,评估抗血栓药物与脑微出血(CMB)的关联。结果显示抗凝药与CMB存在及数量相关,抗血小板药无此关联;CMB阳性者中 amyloid PET 负荷与CMB数量相关。
要点
- 抗凝药使用与脑微出血存在相关,抗血小板药未显示相关。
- 高龄、男性、抗凝药使用是CMB存在的预测因素。
- CMB阳性者中,男性与amyloid负荷预测CMB数量。
核心结论
- 抗凝药使用与一般人群脑微出血存在相关。
- amyloid PET负荷与CMB阳性者的微出血数量相关。
研究设计与样本
- 基于人群的梅奥衰老研究,纳入1253例接受T2*梯度回波MRI的受试者。
- 采用多变量logistic回归、有序logistic模型和结构方程模型分析。
主要发现
- 单用抗血小板药678例中185例(27.3%)有CMB。
- 单用抗凝药95例中43例(45.3%)有CMB。
- 抗凝药联合抗血小板药44例中21例(48.8%)有CMB。
- 抗凝药与CMB存在及频率相关,抗血小板药无显著相关。
关键数值与推荐
- CMB存在预测因素包括MRI时高龄、男性、抗凝药使用。
- CMB阳性组CMB数量预测因素为男性与amyloid负荷。
临床怎么用
- 对使用抗凝药的患者,应关注脑微出血的存在及数量。
- 抗血小板药与CMB的关联在本研究中未得到支持。
局限性
- 横断面设计无法确定因果关系。
- 抗凝药与抗血小板药联合组样本量较小(44例)。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND PURPOSE: Cerebral microbleeds (CMBs) are represented by small areas of hemosiderin deposition, detected on brain magnetic resonance imaging (MRI), and found in ≈23% of the cognitively normal population over age of 60 years. CMBs predict risk of hemorrhagic and ischemic stroke. They correlate with increased cardiovascular mortality. In this article, we sought to determine in a population-based study whether antithrombotic medications correlate with CMBs and, if present, whether the association was direct or mediated by another variable. METHODS: The study consisted of 1253 participants from the population-based Mayo Clinic Study of Aging who underwent T2* gradient-recalled echo magnetic resonance imaging. We tested the relationship between antithrombotic medications and CMB presence and location, using multivariable logistic-regression models. Ordinal logistic models tested the relationship between antithrombotics and CMB frequency. Using structural equation models, we assessed the effect of antithrombotic medications on presence/absence of CMBs and count of CMBs in the CMB-positive group, after considering the effects of age, sex, vascular risk factors, amyloid load by positron emission tomography, and apoE. RESULTS: Two hundred ninety-five participants (26.3%) had CMBs. Among 678 participants taking only antiplatelet medications, 185 (27.3%) had CMBs. Among 95 participants taking only an anticoagulant, 43 (45.3%) had CMBs. Among 44 participants taking an anticoagulant and antiplatelet therapy, 21 (48.8%) had CMBs. Anticoagulants correlated with the presence and frequency of CMBs, whereas antiplatelet agents were not. Structural equation models showed that predictors for presence/absence of CMBs included older age at magnetic resonance imaging, male sex, and anticoagulant use. Predictors of CMB count in the CMB-positive group were male sex and amyloid load. CONCLUSIONS: Anticoagulant use correlated with presence of CMBs in the general population. Amyloid positron emission tomography correlated with the count of CMBs in the CMB-positive group.
引用
- Graff-Radford J, Lesnick T, Rabinstein AA, et al. Cerebral Microbleeds: Relationship to Antithrombotic Medications. Stroke. 2021. PMID: 33966498. doi:10.1161/STROKEAHA.120.031515
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。